Adolescent Autism Study
The Tapestry Study is researching an experimental treatment, AB-2004, that is designed to adsorb certain substances produced by bacteria in the gut to reduce their ability to enter the bloodstream and reach the brain. Scientific studies have s...
About
A randomized, double-blind, placebo-controlled Study of the efficacy, safety, and tolerability of AB-2004 in an autism spectrum disorder population.
AXL-2004-002
Eligibility Criteria
Inclusion Criteria:
- Must be 5 to 17 years old
- Clinically diagnosed and documented Autism Spectrum Disorder (ASD)
- Therapeutic regimen must be stable for at least 30 days prior to screening visit
Exclusion Criteria:
- Is immunocompromised
- History of inflammatory bowel disease, bowel obstruction, diverticulosis, or colon polyps
- History of significant gastric or intestinal surgery
- Current use of an oral controlled or extended-release medication
- Current use of antipsychotics (e.g., aripiprazole or risperidone)
Primary Investigator
Diplomate of the American Board of Psychiatry and Neurology, Inc., a member Board of the American Board of Medical Specialties; Professor and Program Director Clinical Trials Research; Department of Psychiatry and Behavioral Medicine; Carilion Clinic-Virginia Tech Carilion School of Medicine; Virginia Tech Faculty of Health Sciences.
